A recent qualitative investigation among parents of children with PKU and adults with this condition also suggests that the inattentiveness symptoms measured in the ADHD RS-IV and the ASRS, respectively, are relevant among persons with PKU (Mooney et al. 2013 ).
Results of psychometric analyses presented here demonstrated that the 9-item ADHD RS-IV and the ASRS inattentiveness subscales are reliable, valid, responsive, and robust measures of inattentiveness among persons with PKU ages ≥8 years.
The clinical trial data for this psychometric evaluation created a valuable opportunity to test the ADHD RS-IV and ASRS measurement characteristics by utilizing the parent-and selfreported measures that were incorporated into this Phase 3b trial.
This study's findings on the robust measurement characteristics for these two ADHD inattentiveness symptoms measures in a PKU population, and in concert with the prior qualitative support of their importance, establishes their appropriateness for measuring these symptoms in people with PKU. Moreover, these findings provide PKU clinical teams with the validated tools to incorporate inattentiveness screening into routine clinical care for persons with PKU ages ≥8 years, an important part of evaluating mental health/cognitive impairment (Cunningham et al. 2012 ).
Subjects and Study Design
The design of the PKU-016 (clinicaltrials.gov: NCT01114737) trial has been described previously.
Briefly, this study included male and female participants ≥8 years old who have a confirmed diagnosis of PKU. All subjects provided informed consent at study entry.
This post hoc analysis included data from the enrolled population or intent to treat (ITT) population from Study PKU-016, defined as all subjects randomized to treatment. In addition, the analyses were analyzed by age (parents of children <18 years old and adults age ≥18 years old).
Analysis Design

Measures
Neuropsychiatric assessments were made using the ADHD RS-IV, ASRS, Clinical Global Impressions-Improvement (CGI-I) and Clinical Global Impressions-Severity (CGI-S), and the Behavior Rating Inventory of Executive Function (BRIEF and BRIEF-Adult) Parent-and Self-Report Versions.
The ADHD RS-IV is a parent rating scale of symptoms of ADHD in children, and comprises of 18 items based on DSM-IV criteria which contribute to two subscales: inattentiveness and hyperactivity/impulsivity. This analysis focuses on the inattentiveness subscale, which ranges from 0 to 27, with higher scores indicating greater inattentiveness symptom severity.
The ASRS is an adult self-rated scale of symptoms of ADHD, and similar to the ADHD RS-IV, it is comprised of 18 items based on DSM-IV criteria which contribute to two subscales: inattentiveness and hyperactivity/impulsivity. This analysis focuses on the inattentiveness subscale, which ranges from 0 to 27, with higher scores indicating greater inattentiveness symptom severity.
The CGI-I and CGI-S are both one-item, clinician-reported assessments of patient illness. The CGI-I reports how much the patient's illness has improved or worsened relative to baseline, while the CGI-S rates the severity of the patient's illness at the time of assessment relative to the clinician's past experience with patients who have the same diagnosis. Both measures range from 1 to 7, with higher scores indicating worse illness.
The BRIEF was developed to assess everyday behavior by recording common descriptors of executive function-related behaviors. The Parent Form (BRIEF) contains 86 items within 8 clinical scales. The Adult Form (BRIEF-A) contains 75 items within 9 clinical scales. This analysis focuses on the Working Memory subscale of the BRIEF and BRIEF-A, which have been normalized to t-scores, with a mean of 50 and standard deviation of 10 for both measures.
Reliability Assessments
Test-retest reliability of the ADHD RS-IV and ASRS inattentiveness subscales was assessed in the child and adult data subjects meeting the stable definition; stable subjects were defined as those in the placebo arm with no change (score of 4) on the CGI-I at Week 4 (re-test visit) (Streiner & Norman 2002). Intraclass correlation coefficients (ICC) were assessed to evaluate the degree of association between the ADHD RS-IV and ASRS inattentiveness subscales scores at Baseline and Week 4.
Internal consistency reliability was also assessed on the ADHD RS-IV and ASRS inattentiveness subscales in the child and adult PKU populations using a Cronbach's alpha (α) lowerbound threshold of 0.70 to indicate that the items in each of the subscales were measuring the same construct (Nunnally & Bernstein 1994 ).
Validity Assessments
Known-groups validity was assessed on the ADHD RS-IV and ASRS inattentiveness subscales using the CGI-S as a clinical measure of the patient disease status at the baseline visit. Using the child and adult data, separate known-groups analyses using analysis of variance (ANOVA) were conducted comparing the ADHD RS-IV and ASRS inattentiveness mean scales scores across categorizations of the CGI-S defined as CGI-S scores 1-2, CGI-S scores 3-5, and CGI-S scores 6-7 (Abetz et al. 2005 ).
Convergent validity analyses were conducted at Baseline and Week 13, and Pearson and Spearman correlation coefficients were assessed to examine the convergent validity of the ADHD RS-IV and ASRS inattentiveness scores with scores from the CGI-S and the BRIEF Working Memory subscale (adult dataset was based on the BRIEF-A Working Memory subscale).
Thresholds for establishing convergent validity were set at a magnitude r≥|0.30| based on prior research (Nunnally & Bernstein 1994).
RESULTS
Reliability Results
Test-retest reliability of the inattentive symptoms score of the ADHD RS-IV (ICC=0.87; n=25) and the ASRS (0.89; n=25) indicated outstanding agreement (Landis & Koch 1977) between the Baseline and Week 4 retest visit in the stable placebo-arm subsample.
Internal consistency reliability testing for the two measures at Baseline (ADHD RS-IV and ASRS) were 0.93 and 0.87, respectively, demonstrating strong internal consistency.
Validity Results
Known-groups validity of the inattentive symptoms scores for the ADHD RS-IV and the ASRS was demonstrated at Baseline using CGI-S scores; statistically significant (p<0.05) overall and pairwise comparisons for the mean ADHD RS-IV and ASRS inattentive symptoms scores were observed (Table 3) .
For convergent validity analysis, the correlations with the CGI-S were consistently moderate (r≥0.56) in magnitude at Baseline (Table 4) . Correlations with the BRIEF Working Memory subscale were strong in magnitude for all measures (r≥0.76; Table 4 ).
Ability to Detect Change Results
With the exception of the correlation of the ASRS inattentiveness change score with the change score for the CGI-S (r=0.28), all of the correlations between the ADHD RS-IV and the ASRS inattentive symptoms change scores (Baseline to Week 13) and respective change scores for the CGI-S and the BRIEF Working Memory subscale were moderate in magnitude (r=0.34 to 0.47), with all correlations statistically significant (p<0.001) ( Table 5) .
Results of the ability to detect change assessment demonstrated that these measures are sensitive enough to detect change in other relevant measures.
Ability to Detect Change
The ability to detect change was examined using change scores calculated over the Baseline to Week 13 time span. Correlations between the ADHD RS-IV and ASRS inattentiveness change scores, and the change scores for the CGI-S and the BRIEF Working Memory subscale, were measured using Pearson's correlation (r). Similar to the convergent validity analysis, thresholds for establishing responsiveness on the ADHD RS-IV and ASRS inattentiveness score correlations with items or scales measuring similar concepts were set at a magnitude r≥|0.30| (Nunnally & Bernstein 1994) .
Statistical Analysis
Descriptive statistics were provided, including means, standard deviations, medians, and percents.
All statistical analyses were performed using SAS® v9.2, and statistical significance was set at p<0.05.
